DMPK > 항암유효성평가지원센터

The efficiency of drug development will be improved by screening the effectiveness and stability of the drug candidate through a DMPK (Drug Metabolism and Pharmacokinetics) study

PK study using assay system and animal model for In vitro ADME profiling

Mouse / Rat

Analysis of drug concentrations in the blood or tissue after animal modeling

Rabbit / Dog

Analysis of requested samples such as plasma and PK parameter calculation

Service

  • Bioanalysis
    • Development of quantitative analysis method using pre-treatment of samples and LC-MS/MS
    • Development of pre-treatment and quantitative Analysis Method Using LC-MS/MS
  • In vitro ADME assay
    • Parallel artificial membrane permeability assay (PAMPA)
    • Caco-2 permeability assay
    • Protein binding assay
    • Microsomal stability
    • Plasma stability
    • CYP inhibition study
    • In vitro metabolite identification (Met ID)
  • In vivo PK study
    • Rodent (mouse/rat) full PK study
    • Sample analysis and PK parameter calculation when providing PK samples (e.g., plasma) of medium and large animals
    • Tissue distribution experiment
    • N-in-one PK study

In vivo PK study

대사안정성 시험 (Microsomal stability)

Service example (New Zealand white rabbit)

  • New Zealand white rabbit stable PK test

Test content

- Blood was collected from the ear vein of a New Zealand white rabbit at a designated time point after a single administration of the developed material.

- Collected blood is collected in a sodium heparin tube and centrifuged at 4℃, 3000rpm for 10 minutes to separate plasma.

- Presents the pharmacokinetic characteristics of the developed drug for the test subject from the blood-drug concentration curve over time calculated through analysis

Result

 

[Blood collection time point]

[Analysis]

Service example (SD rat)

  • SD rat 경구 투여 PK 시험

Test content

- Blood was collected at a volume of 0.5 mL through the caudal vein of male and female SD rats at each time point.

- Collected blood is collected in a sodium heparin tube and centrifuged at 4℃, 3,000rpm for 10 minutes to separate plasma.

- Presents the pharmacokinetic characteristics of the developed drug for the test subject from the blood-drug concentration curve over time calculated through analysis

Result

 

[Blood collection time point]

[Analysis]